戻る Agenda
LS38 What Systems/Infrastructure Can Be Used for Pediatric Drug Development?
Session Chair(s)
Kayoko Kikuchi, PHD
Development Office for Translational Research, Fujita Health University, Japan
Speaker(s)
Hidefumi Nakamura, MD, PHD
Director for Clinical R&D,, National Center for Child Health and Development, Japan
Miyako Matsumizu, MPHARM
, Pfizer R&D Japan G.K., Japan
Seiko Bun
, Ministry of Health, Labour and Welfare (MHLW), Japan
Kana Harada
Child Life Specialist, Toho University Omori Medical Center, Japan
